Amended and Restated Change in Control AgreementChange in Control Agreement • August 14th, 2012 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations • Maryland
This Amended and Restated Change in Control Agreement (this “Agreement”) is effective as of July 2, 2012, by and between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and J.J. Finkelstein (the “Executive”).
